Memphis Mobile Stroke Unit Saves Lives
A year after a mobile stroke unit hit the streets of Memphis, officials say it is saving lives by cutting the time it takes to treat stroke patients.
The University of Tennessee Health Science Center began using the 14-ton ambulance last year as part of a three-year controlled study. The unit has a CT scanner that can X-ray images of the brain, and is equipped to provide early fluids to stroke patients and dye blood vessels to determine the type of stroke the patient has had.
"The emergency room on average takes 40 to 50 minutes to do the things we do in 13 to 14 minutes," said Dr.Andrei Alexandrov, UTHSC neurolo...
Source: JEMS Special Topics - June 10, 2017 Category: Emergency Medicine Authors: Olivia Peterkin, The Commercial Appeal Tags: News Mobile Integrated Healthcare Source Type: news
NOR-TEST: Tenecteplase Similar to Alteplase in Stroke NOR-TEST: Tenecteplase Similar to Alteplase in Stroke
The newer thrombolytic given as a bolus dose showed functional and safety outcomes similar to those of alteplase infusion in the NOR-TEST trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 19, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Lori’s Stroke Required Help From Doctors An Hour Away. Telemedicine Provided It.
Editor’s note: Our previous stories this American Stroke Month featured warning signs heeded and missed. Today we shift gears to showcase a textbook response to a stroke, including the crucial role of telestroke, a way for experts at another facility to help care for a patient via a webcam-type connection. The CHRONIC Care Act, which includes a provision to require Medicare to cover telestroke, will be discussed Tuesday during a hearing of the Senate Finance Committee.
Lori Hoopingarner savored her occasional weekend getaway.
Between running her financial advising company, raising a 10-year-old daughter and 6-year-old s...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news
MassDevice.com +5 | The top 5 medtech stories for February 24, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. FDA panel supports Claret Medical’s Sentinel, despite efficacy questions
The FDA’s Circulatory System Devices Panel this week gave its support to de novo clearance for Claret Medical’s Sentinel embolic protection dev...
Source: Mass Device - February 24, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: News Well Plus 5 Source Type: news
Stroke Care: A Balanced Approach to the tPA Debate
In conclusion, alteplase is the only treatment available for acute ischemic stroke that is effective in some patients. In order to improve tPA effectiveness and minimize risks, patients with symptoms suggestive of an AIS should get rapid assessment and treatment with tPA after careful review of the contraindications. Given that smaller strokes can still be associated with considerable long term neurological morbidity, treatment should still be considered in those patients after weighing the risks and benefits and in consultation with the patient and family. Advanced age should also not be a limiting factor. Although the NI...
Source: EPMonthly.com - December 31, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news
alteplase (TPA, Activase, Cathflo Activase)
Title: alteplase (TPA, Activase, Cathflo Activase)Category: MedicationsCreated: 12/19/2000 12:00:00 AMLast Editorial Review: 11/3/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 3, 2016 Category: Cardiology Source Type: news
A Paradigm Shift in EMS Evaluation Of Stroke
BackgroundMontgomery County Hospital District EMS (MCHD) is collaborating with the South East Texas Regional Advisory Committee (SETRAC) to validate their existing prehospital suspected neurological event guideline for stroke assessment and transport.MCHD is a non-fire based EMS service in Montgomery County, Texas. We respond to approximately 58,000 calls to service and identify stroke in more than 500 patients per year. Our EMS system covers an estimated 1,100-square-mile service area and has 190 medics, 900 EMTs and 15 first responder (FR) organizations.Acute ischemic stroke (AIS) is a debilitating and costly disease wit...
Source: JEMS Patient Care - August 12, 2016 Category: Emergency Medicine Authors: Robert L. Dickson, MD, FAAEM, FACEP, FACEM Tags: Patient Care Source Type: news
A Paradigm Shift in EMS Evaluation Of Stroke
Background
Montgomery County Hospital District EMS (MCHD) is collaborating with the South East Texas Regional Advisory Committee (SETRAC) to validate their existing prehospital suspected neurological event guideline for stroke assessment and transport. MCHD is a non-fire based EMS service in Montgomery County, Texas. We respond to approximately 58,000 calls to service and identify stroke in more than 500 patients per year. Our EMS system covers an estimated 1,100-square-mile service area and has 190 medics, 900 EMTs and 15 first responder (FR) organizations.
Acute ischemic stroke (AIS) is a debilitating and costly disease ...
Source: JEMS Patient Care - August 12, 2016 Category: Emergency Medicine Authors: Robert L. Dickson, MD, FAAEM, FACEP, FACEM Tags: Patient Care Source Type: news
Alteplase confers long-term survival benefit after stroke
Alteplase treatment in patients with acute ischaemic stroke is associated with a survival benefit among those who survive the acute phase, shows further analysis of IST-3. (Source: MedWire News)
Source: MedWire News - July 26, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
MHRA review confirms benefit/risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news
NICE recommends treatment with alteplase is started as early as possible, within 4.5 hours of onset of ischaemic stroke symptoms
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news
Activase (Alteplase) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2016 Category: Drugs & Pharmacology Source Type: news
alteplase (Activase, Cathflo Activase, TPA)
Title: alteplase (Activase, Cathflo Activase, TPA)Category: MedicationsCreated: 12/19/2000 12:00:00 AMLast Editorial Review: 5/31/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 31, 2016 Category: Drugs & Pharmacology Source Type: news
Reducing doses of common stroke drug 'could save thousands of lives'
Reducing the dose of alteplase – taken by one in nine stroke patients – would slash brain bleeds by two thirds and death rates by a sixth, according to an international study led by Leicester University. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2016 Category: Consumer Health News Source Type: news
